16 research outputs found

    Hydrothermal activity in the Lau Basin: First results from the NAUTILAU Cruise

    No full text
    The Lau Basin, a back arc spreading center, is one of the most active hydrothermal areas in the ocean. A scientific team from France, Germany, and Tonga investigated the southern Lau Basin near Tonga in 1989 to study the processes of seafloor ore-mineral formation associated with hydrothermal circulation along the volcanic Valu Fa ridge (Ride de Valu Fa in Figure 1), which lies in back of the Tonga-Kermadec trench. Between April 17 and May 10 scientists on the R/V Nadir used the submersible Nautile to make 22 dives in the southern Lau Basin. The cruise was called NAUTILAU, for Nautile in Lau Basin. In addition to the standard equipment of the submersible (video and photo cameras, and temperature probe), a CTD (conductivity-temperature-depth) instrument was integrated with a “mini rosette” water sampling device used for the first time on the Nautile to obtain correlations between the geological observations and the physical and chemical anomalies measured in the seawater

    The clinical significance of body weight loss in idiopathic pulmonary fibrosis patients

    No full text
    BACKGROUND: The significance of the nutritional status in idiopathic pulmonary fibrosis (IPF) is largely unknown. Temporal body weight (BW) change, a dynamic index of nutrition status, can detect the malnutrition more accurately than the conventional single-point body mass index evaluation. OBJECTIVE: To investigate how the temporal BW change influences the clinical courses of IPF. METHODS: This multicenter study enrolled IPF patients from four referral hospitals of interstitial lung diseases in Japan (the Japanese cohort, the derivation cohort) and the Royal Brompton Hospital (the UK cohort, the validation cohort). The annual rate of BW change from the initial presentation was evaluated. A > 5% decrease of BW was defined as a significant BW loss. RESULTS: Twenty-seven out of 124 patients in the Japanese cohort and 13 out of 86 patients in the UK cohort showed significant BW loss. Patients with BW loss showed significantly worse survival in both cohorts. Multivariate analyses revealed that BW loss was an independent factor for decreased survival (Japanese cohort: p = 0.047, UK cohort: p = 0.013). A 6.1% loss of BW was chosen as the optimal cutoff value to predict the 2-year mortality from the initial presentation. The stratified analysis revealed that a 6.1% or greater BW loss could predict worse survival specifically in cases without a greater than 10% decline in forced vital capacity (FVC). CONCLUSIONS: BW loss is independently associated with the survival of IPF patients, particularly when a decline in the FVC was not observed. Further studies are needed to understand the mechanisms underlying BW loss in IPF

    La enfermedad del adyuvante en ratas infectadas experimentalmente con Trypanosoma cruzi

    Get PDF
    Se estudió la evolución de la artritis por adyuvante en ratas que habían sido infectadas previamente con Trypanosoma cruzi, con el objeto de evaluar su competencia inmunológica a través de la respuesta artrítica. La artritis por adyuvante se indujo en ratas adultas, endocriadas de ambos sexos, con 0.1 mi de adyuvante completo de Freund en la almohadilla plantar, en 2 lotes: a) inyectadas 90 días antes con 1 x 10(6) T. cruzi y b) testigos normales simultáneos. Se midieron, la lesión artrítica macroscópicamente con una escala semicuantitativa, y con microscopía óptica la histopatología de la lesión local y la del corazón, a los 180 días post-infecoión. La magnitud de las lesiones artríticas en las ratas con T. cruzi fue significativamente menor (p < 0.001) que la de los testigos, en todo el período. El infiltrado inflamatorio local, formado por linfocitos, plasmocitos y macrófagos fue significativamente menor (p < 0.001) en las ratas chagásicas, con respecto al de los testigos. Se postula que en las ratas que recibieron T. cruzi la respuesta artrítica menor podría deberse a una competición antigénica con los determinantes del parásito o a mecanismos inmunosupresores que interfieren en la producción de la entidad experimental
    corecore